Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CBOE NASDAQ:HST NYSE:JEF NYSE:MRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCBOECboe Global Markets$237.84+0.3%$227.89$179.80▼$239.25$24.90B0.43854,015 shs701,623 shsHSTHost Hotels & Resorts$16.06-0.6%$15.65$12.22▼$19.37$11.14B1.318.80 million shs7.19 million shsJEFJefferies Financial Group$56.35+2.5%$52.85$39.28▼$82.68$11.62B1.461.70 million shs1.51 million shsMRXMedicis Pharmaceutical$38.75+19.1%$0.00$18.13▼$49.34$2.73BN/A629,016 shs415,945 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCBOECboe Global Markets+1.35%+1.99%+5.62%+9.23%+23,709,999,900.00%HSTHost Hotels & Resorts-1.10%0.00%+3.26%+18.23%-12.98%JEFJefferies Financial Group+0.16%+0.28%+2.00%+28.52%-3.18%MRXMedicis Pharmaceutical-1.03%-0.01%-0.06%+1.45%+93.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCBOECboe Global Markets3.0042 of 5 stars2.00.02.52.53.92.51.3HSTHost Hotels & Resorts4.0569 of 5 stars2.32.02.51.93.41.71.9JEFJefferies Financial Group4.523 of 5 stars2.33.02.52.33.22.52.5MRXMedicis Pharmaceutical0.6129 of 5 stars2.40.01.70.00.60.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCBOECboe Global Markets 1.92Reduce$222.58-6.41% DownsideHSTHost Hotels & Resorts 2.54Moderate Buy$17.9611.84% UpsideJEFJefferies Financial Group 2.50Moderate Buy$66.0017.13% UpsideMRXMedicis Pharmaceutical 2.75Moderate Buy$45.4317.23% UpsideCurrent Analyst Ratings BreakdownLatest MRX, CBOE, JEF, and HST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2025HSTHost Hotels & ResortsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform7/15/2025CBOECboe Global MarketsOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$249.00 ➝ $253.007/15/2025CBOECboe Global MarketsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$245.00 ➝ $250.007/15/2025CBOECboe Global MarketsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetUnderweight ➝ Underweight$215.00 ➝ $218.007/14/2025MRXMedicis PharmaceuticalTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$54.007/10/2025CBOECboe Global MarketsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$245.00 ➝ $243.007/8/2025CBOECboe Global MarketsCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$230.00 ➝ $245.007/1/2025HSTHost Hotels & ResortsWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$16.00 ➝ $18.006/26/2025JEFJefferies Financial GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $54.006/23/2025HSTHost Hotels & ResortsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$16.006/23/2025JEFJefferies Financial GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$41.00 ➝ $55.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCBOECboe Global Markets$4.09B6.08$12.25 per share19.42$40.88 per share5.82HSTHost Hotels & Resorts$5.81B1.92$2.07 per share7.77$9.46 per share1.70JEFJefferies Financial Group$10.41B1.12$4.78 per share11.78$50.33 per share1.12MRXMedicis Pharmaceutical$1.24B2.19N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCBOECboe Global Markets$764.90M$7.6332.9424.601.7518.64%22.02%10.73%N/AHSTHost Hotels & Resorts$697M$0.9616.738.28N/A11.66%10.11%5.26%7/30/2025 (Estimated)JEFJefferies Financial Group$743.38M$2.6521.269.15N/A7.70%6.59%1.02%9/24/2025 (Estimated)MRXMedicis Pharmaceutical$141.30MN/A0.0013.23N/AN/AN/AN/AN/ALatest MRX, CBOE, JEF, and HST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025HSTHost Hotels & Resorts$0.51N/AN/AN/A$1.51 billionN/A6/25/2025Q2 2025JEFJefferies Financial Group$0.44$0.40-$0.04$0.40$1.64 billion$1.63 billion5/18/2025N/AMRXMedicis Pharmaceutical$0.90$0.97+$0.07N/AN/AN/A5/2/2025N/ACBOECboe Global Markets$2.36$2.50+$0.14N/AN/AN/A4/30/2025Q1 2025HSTHost Hotels & Resorts$0.56$0.64+$0.08$0.64$1.55 billion$1.59 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCBOECboe Global Markets$2.521.06%N/A33.03%1 YearsHSTHost Hotels & Resorts$0.804.98%N/A83.33%2 YearsJEFJefferies Financial Group$1.602.84%N/A60.38%2 YearsMRXMedicis Pharmaceutical$0.561.45%N/AN/AN/ALatest MRX, CBOE, JEF, and HST DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/26/2025JEFJefferies Financial Groupquarterly$0.402.9%8/18/20258/18/20258/29/20256/12/2025HSTHost Hotels & Resortsquarterly$0.205.1%6/30/20256/30/20257/15/20255/6/2025CBOECboe Global Marketsquarterly$0.631.08%5/30/20255/30/20256/13/20255/13/2025MRXMedicis Pharmaceuticalquarterly$0.151.23%5/27/20255/27/20256/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCBOECboe Global Markets0.341.781.39HSTHost Hotels & Resorts0.762.082.08JEFJefferies Financial Group1.681.051.05MRXMedicis Pharmaceutical1.181.041.08Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCBOECboe Global Markets82.67%HSTHost Hotels & Resorts98.52%JEFJefferies Financial Group60.88%MRXMedicis PharmaceuticalN/AInsider OwnershipCompanyInsider OwnershipCBOECboe Global Markets0.22%HSTHost Hotels & Resorts1.40%JEFJefferies Financial Group19.80%MRXMedicis Pharmaceutical3.79%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCBOECboe Global Markets1,540104.71 million104.46 millionN/AHSTHost Hotels & Resorts160693.71 million684.00 millionOptionableJEFJefferies Financial Group7,822206.28 million165.44 millionOptionableMRXMedicis Pharmaceutical2,07470.29 million67.63 millionOptionableMRX, CBOE, JEF, and HST HeadlinesRecent News About These CompaniesBest Value Stocks to Buy for July 17thJuly 17 at 5:56 AM | zacks.comWall Street Analysts Believe Marex Group PLC (MRX) Could Rally 30.56%: Here's is How to TradeJuly 16 at 10:56 AM | zacks.comMarex Group PLC (MRX) Upgraded to Buy: Here's WhyJuly 15 at 1:01 PM | zacks.comMarex Group plc to Announce Second Quarter 2025 Results on August 13, 2025July 14 at 5:03 PM | globenewswire.comMarex completes acquisition of FX specialist Hamilton Court GroupJuly 1, 2025 | globenewswire.comMarex Group plc added to membership of Russell 3000® IndexJune 30, 2025 | globenewswire.comMarex Group plc to Participate in Upcoming Piper Sandler Global Exchange & Trading ConferenceJune 2, 2025 | globenewswire.comBest Momentum Stock to Buy for May 30thMay 30, 2025 | zacks.comNew Strong Buy Stocks for May 30thMay 30, 2025 | zacks.comMarex Group plc (MRX) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comMarex announces departure of Roger Nagioff from the Group BoardMay 15, 2025 | globenewswire.comMarex Group plc announces strong results for first quarter of 2025May 15, 2025 | globenewswire.com5 Stocks With Recent Price Strength to Maximize Your GainsMay 9, 2025 | zacks.comMarex Group plc Announces Pricing of U.S.$500 Million Senior Notes OfferingMay 2, 2025 | globenewswire.comFitch updates Marex's outlook to positive due to strong earnings and diversification of franchiseApril 30, 2025 | globenewswire.comMarex Group Plc to Announce First Quarter 2025 Earnings on May 15, 2025April 24, 2025 | globenewswire.com5 Stocks With Recent Price Strength Amid Tariff-Led VolatilityApril 23, 2025 | zacks.comMarex Group plc Announces Pricing of the Public OfferingApril 17, 2025 | globenewswire.comBest Momentum Stocks to Buy for April 15thApril 15, 2025 | zacks.comNew Strong Buy Stocks for April 15thApril 15, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseJefferies Raises Broadcom Price Target to $315: 19% Upside AheadBy Leo Miller | July 2, 2025View Jefferies Raises Broadcom Price Target to $315: 19% Upside AheadMRX, CBOE, JEF, and HST Company DescriptionsCboe Global Markets NASDAQ:CBOE$237.84 +0.74 (+0.31%) As of 04:00 PM EasternCboe Global Markets, Inc. is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. Cboe offers trading across a diverse range of products in multiple asset classes and geographies, including options, futures, U.S. and European equities, exchange-traded products (ETPs), global foreign exchange (FX) and multi-asset volatility products based on the VIX Index. Cboe's trading venues include the largest options exchange in the United States and the largest stock exchange by value traded in Europe. CBOE reports the results of its operations in 5 business segments: Options, Futures, U.S. Equities, European Equities, and Global FX.Host Hotels & Resorts NASDAQ:HST$16.06 -0.09 (-0.56%) Closing price 04:00 PM EasternExtended Trading$16.08 +0.02 (+0.12%) As of 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Host Hotels & Resorts, Inc. is a real estate investment trust, which engages in the management of luxury and upper-upscale hotels. It operates through the following geographical segments: United States, Brazil, and Canada. The company was founded in 1927 and is headquartered in Bethesda, MD.Jefferies Financial Group NYSE:JEF$56.35 +1.37 (+2.49%) Closing price 03:59 PM EasternExtended Trading$55.75 -0.60 (-1.06%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Investment Banking and Capital Markets, and Asset Management. It provides investment banking, advisory services with respect to mergers or acquisitions, debt financing, restructurings or recapitalizations, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal bonds, mortgage-backed and asset-backed securities, equity and equity-linked securities, and loan syndication services; and corporate lending services. The company also offers financing, securities lending, and other prime brokerage services; equities research, sales, and trading services; wealth management services; and online foreign exchange trading services. In addition, it provides investment grade distressed debt securities, U.S. and European government and agency securities, municipal bonds, leveraged loans, emerging markets debt, and interest rate and credit index derivative products; and manages and offers services to a diverse group of alternative asset management platforms across a spectrum of investment strategies and asset classes. The company was formerly known as Leucadia National Corporation and changed its name to Jefferies Financial Group Inc. in May 2018. Jefferies Financial Group Inc. was founded in 1962 and is headquartered in New York, New York.Medicis Pharmaceutical NYSE:MRXMedicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta). More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
